On November 27, the first day of the International Conference on Biosafety organized by Joint Stock Company National Holding QazBioPharm took place in Astana.

The event brought together more than 300 participants from Kazakhstan, France, China, and Russia.

The key highlight was the presentation of the results of the three-year program of the Biological Safety Consortium, including test systems, vaccine platforms, and innovative medicinal products ready for implementation.